HOUSE DOCKET, NO. 1946 FILED ON: 1/19/2017
HOUSE . . . . . . . . . . . . . . . No. 1140
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Gerard Cassidy
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act to ensure patient medication adherence.
_______________
PETITION OF:
Name: | District/Address: | Date Added: |
Gerard Cassidy | 9th Plymouth | 1/19/2017 |
HOUSE DOCKET, NO. 1946 FILED ON: 1/19/2017
HOUSE . . . . . . . . . . . . . . . No. 1140
By Mr. Cassidy of Brockton, a petition (accompanied by bill, House, No. 1140) of Gerard Cassidy for legislation to direct the Department of Public Health to implement an institutional pharmacy discharge medication pilot program to ensure patient medication adherence. Public Health. |
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 1915 OF 2015-2016.]
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninetieth General Court
(2017-2018)
_______________
An Act to ensure patient medication adherence.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. (a) The department of public health shall implement an institutional pharmacy discharge medication pilot program for the purposes of ensuring patient medication adherence that shall last for 2 years. Such a program shall: (1) allow institutional pharmacies to be treated like retail pharmacies for the purposes of providing medication to a patient at the time of discharge; and (2) allow hospitals licensed pursuant to section 51 of Chapter 111 of the General Laws and hospital pharmacists that hold a current license to practice pharmacy in the commonwealth to provide a 14-day supply of medication to a patient at the time of discharge and to perform medication review, reconciliation and counseling.
(b) If at the end of the 2-year pilot the department of public health determines that the program has improved medication adherence, the department of public health shall remove any regulatory barriers that prohibit such a program from expanding.